DC

Debasish Chatterjee

Director DIN 01513599
DIN 01513599 First appointment Aug 2007
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Aug 2007
Shareholding value β€’β€’β€’β€’ Premium profile

About Debasish Chatterjee

Data last updated:

Debasish Chatterjee was a Director at Ags Medical Systems Private Limited (from 2007) and Director at Transmed Pharmaceuticals Private Limited (from 2009).

DIN 01513599
First Appointment 14 Aug 2007
Oldest Company Age 19 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ags Medical Systems Private Limited U85195WB2007PTC117847
Director14 Aug 20072007₹2.25 Cr (FY 2016)Strike Off
Director23 Nov 20092009Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ags Medical Systems Private Limited
Transmed Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Debasish Chatterjee

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Debasish Chatterjee

Debasish Chatterjee was first appointed on 14 Aug 2007 as Director at Ags Medical Systems Private Limited. The most recent appointment on record is 23 Nov 2009 at Transmed Pharmaceuticals Private Limited.

Debasish Chatterjee held 2 earlier board appointments: Ags Medical Systems Private Limited (Director, from 14 Aug 2007); Transmed Pharmaceuticals Private Limited (Director, from 23 Nov 2009).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available